BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
70 hedge funds and large institutions have $322M invested in Blueprint Medicines in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
32% less capital invested
Capital invested by funds: $474M → $322M (-$152M)
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
Holders
70
Holding in Top 10
3
Calls
$11.4M
Puts
$43K
Top Buyers
| 1 | +$9.99M | |
| 2 | +$7.44M | |
| 3 | +$7.07M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$6.53M |
| 5 |
VAM
Visium Asset Management
New York
|
+$4.42M |
Top Sellers
| 1 | -$14.8M | |
| 2 | -$11.3M | |
| 3 | -$4.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.62M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.63M |